Non-small cell lung cancer occurs when normal cells grow and multiply
without control after undergoing a cell transformation. Lung cancer is the
leading cause of cancer deaths worldwide, and the incidence of lung cancer is
increasing significantly. Lung cancer is the common cause of mortality and
morbidity not only in developed countries but also in developing countries. One
of the most common types of lung cancer is non-small cell lung cancer. It grows
and spreads quite slowly. Smoking is considered as a major cause of lung cancer,
although lung cancer also occurs in non-smokers. There are three main types of
non-small cell lung cancer: squamous cell (epidermoid) carcinoma,
adenocarcinoma, and large cell (undifferentiated) carcinoma. Some of the common
symptoms associated with non-small cell lung cancer are chest pain, a cough
that does not go away, coughing up blood, fatigue, loss of appetite, losing
weight without trying, shortness of breath, and wheezing.
Analysts forecast the Global Non-small Cell
Lung Cancer market to grow at a CAGR
of 3.62 percent over the period 2013-2018.
Covered in this
Report
This report covers the present scenario and the growth prospects of the
Global Non-small Cell Lung Cancer market for the period 2014-2018. To calculate
the market size, the report considers the revenue generated through various
therapies adopted for the treatment of non-small cell lung cancer, including
·
Biologics
·
Small Molecules
Global Non-small Cell Lung Cancer Market 2014-2018, has been prepared
based on an in-depth market analysis with inputs from industry experts. The
report covers the Americas, and the APAC and EMEA regions; it also covers the
Global Non-small Cell Lung Cancer market landscape and its growth prospects in
the coming years. The report includes a discussion of the key vendors operating
in this market.
Single User License of the Report is Available
at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=23071 .
Key Regions
·
Americas
·
APAC
·
EMEA
Key Vendors
·
AstraZeneca
·
Celgene
·
Eli Lilly
·
F. Hoffmann-La Roche
·
Pfizer
Other Prominent
Vendors
·
Aetna
·
Boehringer Ingelheim
·
Celldex
·
Eisai
·
GlaxoSmithKline
·
IMClone
·
Merck Serono
·
Novartis
·
Qiagen
·
OncoGenex
·
OSI Pharmaceuticals
·
Pierre Fabre
·
Sanofi
·
Synta
